Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03156010 · ClinicalTrials.gov registry record · NA

Oculomotor Assessment of Traumatic Brain Injury (TBI)

A NA study, sponsored by Walter Reed National Military Medical Center.

Completed
Registry status
NA
Development phase
201
Enrollment target

NCT03156010 is a NA study that has completed, run by Walter Reed National Military Medical Center. The registered enrollment target is 201 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03156010, a NA study, has completed, sponsored by Walter Reed National Military Medical Center.

COMPLETED
Registry status
NA
Development phase
201 participants
Enrollment target

Study Summary

The purpose of the proposed study is to compare the sensitivity and specificity of three oculomotor test devices in normal subjects versus subjects with history of TBI. The study is designed as a prospective research project in which a group of 120 normal controls without a history of TBI will be compared to another group of 120 participants (total of 240) who have a confirmed history of TBI. Each participant will complete the TBI assessment protocol for each of three separate devices (Neuro Kinetics, SyncThink, and Oculogica). The order of the devices will be counter-balanced across participants. Participants will also be screened for vestibular migraine and visual vertigo, which are two conditions that influence oculo-vestibular perception in normal and TBI patients and might influence the results from the three oculomotor devices. Data from each device will be utilized to perform AUC analyses to determine the respective sensitivity and specificity for each.

Interventions

  • DEVICE Neuro Kinetics IPAS
  • DEVICE Oculogica EyeBox
  • DEVICE SyncThink EyeSync Device

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2017-09-18
Est. Completion 2023-04-19
Phase NA

What the Registry Record Tells You About NCT03156010

The ClinicalTrials.gov registry entry for NCT03156010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Neuro Kinetics IPAS is the first listed.

NCT03156010 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03156010 about?

NCT03156010 is a clinical study titled "Oculomotor Assessment of Traumatic Brain Injury (TBI)". The purpose of the proposed study is to compare the sensitivity and specificity of three oculomotor test devices in normal subjects versus subjects with history of TBI. The study is designed as a prospective research project in which a group of 120 normal controls without a history of TBI will be co...

What is the current status of trial NCT03156010?

This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2017-09-18. Estimated completion is 2023-04-19.

What interventions are being tested in trial NCT03156010?

The interventions under investigation include: Neuro Kinetics IPAS (DEVICE), Oculogica EyeBox (DEVICE), SyncThink EyeSync Device (DEVICE).

Who is sponsoring clinical trial NCT03156010?

This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.